From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy

por Colin, Morvane, Dujardin, Simon, Schraen-Maschke, Susanna, Meno-Tetang, Guy, Duyckaerts, Charles, Courade, Jean-Philippe, Buée, Luc
Publicado 2019

Hallmarks of neurodegenerative disease: A systems pharmacology perspective

por Bloomingdale, Peter, Karelina, Tatiana, Ramakrishnan, Vidya, Bakshi, Suruchi, Véronneau‐Veilleux, Florence, Moye, Matthew, Sekiguchi, Kazutaka, Meno‐Tetang, Guy, Mohan, Aparna, Maithreye, R., Thomas, Veena A., Gibbons, Frank, Cabal, Antonio, Bouteiller, Jean‐Marie, Geerts, Hugo
Publicado 2022

Efficacy of Epratuzumab, an Anti‐CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials...

por Gottenberg, Jacques‐Eric, Dörner, Thomas, Bootsma, Hendrika, Devauchelle‐Pensec, Valérie, Bowman, Simon J., Mariette, Xavier, Bartz, Holger, Oortgiesen, Marga, Shock, Anthony, Koetse, Willem, Galateanu, Catrinel, Bongardt, Sabine, Wegener, William A., Goldenberg, David M., Meno‐Tetang, Guy, Kosutic, Gordana, Gordon, Caroline
Publicado 2018

Safety, Pharmacokinetic, and Functional Effects of the Nogo-A Monoclonal Antibody in Amyotrophic Lateral Sclerosis: A Randomized, First-In-Human Clinical Trial

por Meininger, Vincent, Pradat, Pierre-François, Corse, Andrea, Al-Sarraj, Safa, Rix Brooks, Benjamin, Caress, James B., Cudkowicz, Merit, Kolb, Stephen J., Lange, Dale, Leigh, P. Nigel, Meyer, Thomas, Milleri, Stefano, Morrison, Karen E., Orrell, Richard W., Peters, Gary, Rothstein, Jeffrey D., Shefner, Jeremy, Lavrov, Arseniy, Williams, Nicola, Overend, Phil, Price, Jeffrey, Bates, Stewart, Bullman, Jonathan, Krull, David, Berges, Alienor, Abila, Bams, Meno-Tetang, Guy, Wurthner, Jens
Publicado 2014